Pharmaceutical APIs

U.S. Increasingly Uneasy About Chinese Pharmaceutical API Dominance

Aug 6, 2019 | China, National Security Risk, Pharmaceutical APIs

In what is becoming an ever more intense escalation between the U.S. and China, the Trump administration considers the increasing use of Chinese-made active ingredients in drugs taken by U.S. troops as a national security risk. Why would the White House consider this...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

U.S. Increasingly Uneasy About Chinese Pharmaceutical API Dominance

Pin It on Pinterest